Charles David Lubner

Affiliations

  • Director at Glycomimetics Inc (CBIO), 2025-06-23
  • at Cargo Therapeutics Inc. (CRGX), 2025-06-20
  • at Dyne Therapeutics Inc. (DYN), 2025-06-04
  • at Arcellx Inc. (ACLX), 2025-05-30
  • at Vor Biopharma Inc. (VOR), 2025-05-23
  • Director at Point Biopharma Global Inc. (PNT), 2023-12-27
  • Director at Gemini Therapeutics Inc. (GMTX), 2022-03-09
  • Executive Vp And Cfo at Ra Pharmaceuticals Inc. (RARX), 2020-04-03
  • Director at Nightstar Therapeutics Plc (NITE), 2019-06-07
  • Svp And Cfo at Tetraphase Pharmaceuticals Inc (TTPH), 2015-08-17
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
PNT $6.85 3,600 $24,660.00 3,600 2022-11-23 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
TTPH $42.92 9,500 $407,740.00 69,270 2015-08-14 Filing
TTPH $48.92 7,500 $366,900.00 69,270 2015-07-14 Filing
TTPH $41.67 7,500 $312,525.00 69,270 2015-06-15 Filing
TTPH $41.29 10,000 $412,900.00 69,270 2015-06-12 Filing
TTPH $39.28 7,316 $287,372.48 79,270 2015-05-14 Filing